US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

OPTIMI HEALTH CORP.

4.02

-0.0650-1.59%

Post-market: 4.020.00000.00%19:30 EDT

Volume:21.41K

Turnover:86.73K

Market Cap:23.02M

PE:-2.89

High:4.20

Open:4.10

Low:4.00

Close:4.09

52wk High:8.84

52wk Low:4.00

Shares:5.73M

Float Shares:4.26M

Volume Ratio:0.83

T/O Rate:0.50%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.3932

EPS(LYR):-0.8329

ROE:-54.36%

ROA:-16.06%

PB:1.86

PE(LYR):-4.83

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Press Release: Optimi Health Appoints Melanie Pump to Board of Directors

Optimi Health Completes Psilocybin Production for Health Canada-Approved Phase 2 MDD Trial and Commercial TRD Supply

Press Release: Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer

Optimi Health to Start Phase 2 Trial of Psilocybin-Assisted Therapy for Major Depressive Disorder in H1 2027

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/OPTH"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"OPTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OPTH\",,,,,undefined,":{"symbol":"OPTH","market":"US","secType":"STK","nameCN":"OPTIMI HEALTH CORP.","latestPrice":4.02,"timestamp":1791576000000,"preClose":4.085,"halted":0,"volume":21409,"hourTrading":{"tag":"盘后","latestPrice":4.02,"preClose":4.02,"latestTime":"19:30 EDT","volume":206,"amount":842.24,"timestamp":1791588604271,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.015911872705018457,"floatShares":4256300,"shares":5725900,"eps":-1.393183,"marketStatus":"Market Closed","change":-0.065,"latestTime":"10-09 16:00:00 EDT","open":4.1,"high":4.2,"low":4,"amount":86730.42808,"amplitude":0.04896,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.393183,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"listingDate":1779336000000,"exchange":"NASDAQ","adjPreClose":4.085,"preHourTrading":{"tag":"盘前","latestPrice":4.2,"preClose":4.085,"latestTime":"09:12 EDT","volume":350,"amount":1459.9997999999998,"timestamp":1791551567002,"change":0.115,"changeRate":0.028152,"amplitude":0.009792},"postHourTrading":{"tag":"盘后","latestPrice":4.02,"preClose":4.02,"latestTime":"19:30 EDT","volume":206,"amount":842.24,"timestamp":1791588604271,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8263151841993505},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OPTH\",,,,,undefined,":{"symbol":"OPTH","floatShares":4256300,"roa":"-16.06%","roe":"-54.36%","lyrEps":-0.832942,"volumeRatio":0.8263151841993505,"shares":5725900,"dividePrice":0,"high":4.2,"amplitude":0.04896,"preClose":4.085,"low":4,"week52Low":4,"pbRate":"1.86","psRate":"186.91","week52High":8.838,"institutionHeld":0,"latestPrice":4.02,"eps":-1.393183,"divideRate":0,"volume":21409,"delay":0,"ttmEps":-1.393183,"open":4.1,"prevYearClose":6.852,"prevWeekClose":4.49,"prevMonthClose":4.71,"prevQuarterClose":4.71,"fiveDayClose":4.49,"twentyDayClose":4.42,"sixtyDayClose":4.96},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OPTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-20","symbol":"OPTH","defaultRemindTime":1779283800000,"type":"split","dateTimestamp":1779249600000,"forFactor":30,"toFactor":1,"ratio":30}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OPTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OPTH\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OPTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OPTH","date":"2026-10-09","current":-2.885479,"percent":1,"low":-11.793672,"twenty":-7.28525,"median":-6.591714,"eighty":-5.563703,"high":-4.803734,"avg":-6.72823,"sd":1.581818,"marketCap":23280948.44},"quantilePoints":[{"date":"2026-05-22","current":-11.007427,"twenty":-11.411781,"median":-11.260148,"eighty":-11.108516,"marketCap":31992926.41},{"date":"2026-05-29","current":-10.824906,"twenty":-11.51287,"median":-11.084647,"eighty":-10.895107,"marketCap":31420041.14},{"date":"2026-06-05","current":-8.174559,"twenty":-11.51287,"median":-11.007427,"eighty":-8.434895,"marketCap":31768506.5},{"date":"2026-06-12","current":-5.935667,"twenty":-11.161868,"median":-9.6299,"eighty":-7.029079,"marketCap":22898412.63},{"date":"2026-06-18","current":-6.352205,"twenty":-11.105708,"median":-8.200592,"eighty":-6.747916,"marketCap":24280961.81},{"date":"2026-06-26","current":-6.039801,"twenty":-11.024275,"median":-7.39355,"eighty":-6.143936,"marketCap":22991167.17},{"date":"2026-07-02","current":-7.705953,"twenty":-10.940035,"median":-7.39355,"eighty":-6.175176,"marketCap":29347825.96},{"date":"2026-07-10","current":-6.85205,"twenty":-10.852986,"median":-7.13842,"eighty":-6.289724,"marketCap":26129662.18},{"date":"2026-07-17","current":-7.268589,"twenty":-9.390899,"median":-7.029079,"eighty":-6.289724,"marketCap":27971005.98},{"date":"2026-07-24","current":-6.945772,"twenty":-8.309934,"median":-6.977012,"eighty":-6.49591,"marketCap":26627647.53},{"date":"2026-07-31","current":-6.783033,"twenty":-8.205799,"median":-7.013459,"eighty":-6.600045,"marketCap":26152601.3},{"date":"2026-08-07","current":-7.493132,"twenty":-7.987117,"median":-7.047996,"eighty":-6.633368,"marketCap":28848041.02},{"date":"2026-08-14","current":-7.100988,"twenty":-7.705953,"median":-7.047996,"eighty":-6.697931,"marketCap":27518925.16},{"date":"2026-08-21","current":-5.533835,"twenty":-7.660134,"median":-7.018666,"eighty":-6.258484,"marketCap":27727464.26},{"date":"2026-08-28","current":-5.691471,"twenty":-7.552096,"median":-6.95449,"eighty":-6.106447,"marketCap":28334629.62},{"date":"2026-09-04","current":-5.508946,"twenty":-7.484653,"median":-6.85205,"eighty":-5.789149,"marketCap":27574925.66},{"date":"2026-09-11","current":-5.143895,"twenty":-7.466671,"median":-6.831224,"eighty":-5.659943,"marketCap":25690469.3},{"date":"2026-09-18","current":-5.749547,"twenty":-7.435204,"median":-6.775888,"eighty":-5.64501,"marketCap":28359246.71},{"date":"2026-09-25","current":-5.658284,"twenty":-7.377432,"median":-6.768743,"eighty":-5.651647,"marketCap":27601755.75},{"date":"2026-10-02","current":-5.434276,"twenty":-7.308249,"median":-6.706262,"eighty":-5.628417,"marketCap":26318712.15},{"date":"2026-10-09","current":-4.803734,"twenty":-7.28525,"median":-6.591714,"eighty":-5.563703,"marketCap":23280948.44}],"updateTime":1791671943815},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OPTH\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671219589","title":"Press Release: Optimi Health Appoints Melanie Pump to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2671219589","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671219589?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:30","pubTimestamp":1790681400,"startTime":"0","endTime":"0","summary":"VANCOUVER, British Columbia, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (\"Optimi\" or the \"Company\"), a commercial-stage manufacturer and clinical-stag","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPTH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669745486","title":"Optimi Health Completes Psilocybin Production for Health Canada-Approved Phase 2 MDD Trial and Commercial TRD Supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2669745486","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669745486?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:00","pubTimestamp":1790168400,"startTime":"0","endTime":"0","summary":"One cGMP batch, manufactured in-house under Optimi's Health Canada Drug Establishment Licence, supplies both the Canadian trial and Australian clinicsVANCOUVER, British Columbia, Sept.  23, 2026 (GLOB","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/23/3367523/0/en/optimi-health-completes-psilocybin-production-for-health-canada-approved-phase-2-mdd-trial-and-commercial-trd-supply.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ABVC","OPTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669739142","title":"Press Release: Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2669739142","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669739142?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082000,"startTime":"0","endTime":"0","summary":"VANCOUVER, British Columbia, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (\"Optimi\" or the \"Company\"), a commercial-stage pharmaceutical manufacturer of","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IDNA","MEDX","HYLG","GDOC","OPTH","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666594628","title":"Optimi Health to Start Phase 2 Trial of Psilocybin-Assisted Therapy for Major Depressive Disorder in H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2666594628","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666594628?lang=en_us&edition=fundamental","pubTime":"2026-09-10 22:57","pubTimestamp":1789052267,"startTime":"0","endTime":"0","summary":"Optimi Health  plans to start a phase 2 clinical trial to evaluate psilocybin-assisted therapy in individuals with major depressive disorder in H1 2027, the company said Thursday.Health Canada has approved the trial, which targets to enroll up to 200 participants across several sites in Canada, according to the statement. The trial's primary endpoint is the change in Montgomery-Asberg Depression Rating Scale total score from baseline, Optimi Health said.Price: 4.32, Change: -0.03, Percent Change: -0.69","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPTH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/OPTH\",params:#limit:6,delay:false,,,undefined,":[]}}